Non-canonical TLR4 recognition in Zebrafish: Molecular docking identifies LptD as the primary ligand in Aeromonas hydrophila infection
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Toll-like receptor 4 (TLR4) recognizes lipopolysaccharide (LPS), a key component of Gram-negative bacteria. However, fish TLR4 does not bind to LPS, raising questions about its ligand specificity. In this study, we used the zebrafish TLR4 (ZFTLR4) to propose a non-canonical pathogen-sensing mechanism, where TLR4 directly binds to LptD, an essential protein for LPS assembly. We used an in-silico approach to construct 3D models of ZFTLR4 and the LptD of Gram-negative Aeromonas hydrophila ( Ah LptD), and performed computational analysis that predicted the ZFTLR4- Ah LptD complex is stabilized by extensive molecular interactions which include 15 hydrogen bonds, 1 salt bridge and 225 non-covalent contacts, indicating a high-affinity binding event. The docking results were validated through molecular dynamics (MD) simulations that helped in assessing the stability and conformational dynamics of the complex within a biologically relevant environment. The MD simulation results suggest that TLR4 maintains structural integrity while exhibiting enhanced conformational flexibility and surface accessibility upon binding to its ligand. Our results suggested zebrafish-TLR4 bypasses LPS detection and targets LptD as its primary ligand for immune activation against A. hydrophila . This study bridges a critical knowledge gap in teleost immunology, concluding that fish TLR4 acts as a receptor for LptD, and highlights the significant potential of our findings for the development of new therapeutic targets for bacterial diseases in aquaculture.
Fields of Study & Subjects
Immune Response and Inflammation
Aquaculture disease management and microbiota
Invertebrate Immune Response Mechanisms
Publication details
- Journal / source
- In Silico Research in Biomedicine
- Volume
- 2
- Pages
- 100306–100306
- Publication date
- 1 January 2026
- Language
- EN